Human TCR (IF8) recognizes IL-17R peptide (FITGISILL) in the context of HLA-DRB5. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2670z | Mouse Anti-IL17RA Recombinant Antibody (clone 42A2) | WB, FC, Neut | Mouse IgG1 |
MOB-019LC | Rat Anti-Il17ra Recombinant Antibody (clone YC125) | FC, FuncS | Rat IgG |
HPAB-0318-WJ | Human Anti-IL17RA Recombinant Antibody (HPAB-0318-WJ) | ELISA, Neut | Humanized IgG |
HPAB-1557-FY | Human Anti-IL17RA Recombinant Antibody (HPAB-1557-FY) | FC, Inhib | Human IgG |
VS-0723-WK267 | Rabbit Anti-IL17RA Recombinant Antibody (VS-0723-WK267) | ELISA, FC | Rabbit IgG |
There are currently no Customer reviews or questions for VS-0622-YF3978. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.